Company intelligence / Profile preview
Innopharmascreen
Incheon, South Koreainnopharmascreen.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
InnoPharmaScreen is a South Korean biotechnology company specializing in AI-aided drug discovery and proteomics. The company utilizes its proprietary platforms, including PPIExplorer and ProGlu, to identify and develop modulators of protein-protein interactions (PPI). Its primary focus is on targeted protein degradation (TPD) through molecular glue degraders and small molecule inhibitors for oncology and inflammatory diseases. Key programs include IPS-06061, a molecular glue targeting KRAS G12D, and IPS-07004, an NLRP3 inhibitor in clinical development. The company collaborates with partners like DIGMBIO to advance its pipeline of innovative therapies for intractable cancers and chronic inflammatory conditions.
- Therapeutic areas
- OncologyNeurologyImmunologyPulmonology
- Modalities
- Small moleculeMolecular glue therapyMonoclonal antibodyTargeted protein degradation
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
03
Partnerships
DIGMBIO
Beyond the preview
Go deeper on Innopharmascreen.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Innopharmascreen.